Photodynamic Therapy (PDT) Basics and clinical applications
|
|
- Virginia Watson
- 5 years ago
- Views:
Transcription
1 Photodynamic Therapy () Basics and clinical applications D. Roseeuw, S. T kint Department of Dermatology UZBrussel - VUB
2 GOAL of : selective destruction of targeted abnormal cells Light O 2 Photosensitiser ROS O O 2 O 2 2 O 2 It requires the presence of 3 components to form Reactive Oxygen Species 2
3 Upon activation of photosensitiser with the light of specific spectra it transmits the energy to the oxygen Light Photosensitiser excited state O Type-II-reaction Localisation-dependent cellular damage (i.e. plasma membrane, lysosomes, mitochondria) Photosensitiser energetic ground state Cytotoxicity Modulation of cellular function 3
4 Photodynamic therapy requires the presence of 3 components to form Reactive Oxygen Species LIGHT PHOTO - SENSITISER ROS O 2 O 2 O 2 O2 O 2 4
5 Photo-sensitiser N H 2 O C H 3 O Methyl aminolevulinate (MAL) O O 5-Aminolevulinate (ALA) N H 2 O H O 5
6 Metabolic pathway ALA Porphobilinogen Porphobilinogen deaminase MAL Intermediates Haem Ferrochetalase Protoporphyrin IX 6
7 Metvix specificity Application of Metvix leads to formation of porphyrins specifically at the lesion site. 7
8 Metvix penetration 8 Metvix leads to formation of porphyrins at full lesion depth (here 1.2 mm) without affecting underlying tissue.
9 Electromagnetic spectrum X-ray UV 400 nm 700 nm Infrared Microwaves UV C UV B2 UV B1 UV A2 UV A nm 9
10 Wavelength and skin penetration Porphyrin absorption spectrum nm Stratum corneum Epidermis Dermis Subcutis 10
11 Light sources Conventional light sources Lasers Incandescent lamps High pressure/low pressure arc lamps (Light Emission Device) LED LEDL Diode lasers Pulsed dye lasers 11
12 LED lamps l LED lamps: red light of 635 nm for deep penetration l Compact l No calibration needed l Easy to operate, to position and to store l Mobile l Built-in fan (cooler) l Total illumination time: long 12
13 Treatment procedure 1. Lesion preparation Curette to remove loose scales and crust Avoid distressing surrounding skin 13
14 Treatment procedure 2. MAL application Apply Metvix about 1 mm thick Including 5 10 mm normal surrounding skin Cover with occlusive dressing Leave for 3 hours 14
15 Treatment procedure 3. Illumination Wash off Metvix cream with saline Illuminate with red light (630 nm) Distance = 5-8 cm 15
16 Treatment procedure AK treatment Standard 1 session AZ-VUB 2 sessions,1 week apart BCC treatment 2 sessions, one week apart 2 sessions, 1-2 weeks apart 16
17 and Pain Common problem, variable, unpredictable and limiting factor. AK > Bowen > BCC Head > trunk > extremities Large > small lesions Men > women Pale complex phototype I > phototype IV Inflammatory reaction > pain patients Scoring: Visual analogue scale : VAS
18 and Pain Pathophysiology: not well known Pain in -40% - 60% Photoreaction causes pain throught free nn fibers in epidermis direct pain through photoreaction 2 types (depolarisation) indirect pain through inflammation (prostaglandins bradykinine) ALA > MAL { in normal skin in AK (1 studie) 18
19 and Pain Management 1) Cooling - raises pain threshold -> skin temp to 20 C -> 30% pain reduction - 50% do not react on cooling - cooling fans spray water cold air 2) Oral analgetics Time to be efficient Paracetamol Melarnizol Na (metanizol) Tramadol Benzodiazepine 35 min 60 min 90 min 19
20 and Pain Management 3) Block anesthesia (xylocaine type) {! Genital: spinal block hand? 4) Tumescent anesthesia 5) Infiltration: 0,5% (Xylocaine + adr.) 6) EMLA and tetracaine gel: of no help 20
21 Clinical experience Actinic keratosis 21
22 Aims of clinical programme Document safety and efficacy of MAL in treatment of AK Compare with most common therapies Efficacy and safety Cosmetic outcome Patient satisfaction 22
23 Placebo-controlled vs cryotherapy: Used as indicated in non-hyperkeratotic AKs on face and scalp MAL when repeated after one week is more effective than cryotherapy % lesions with complete response at 3 months (Freeman M. et al; J Dermatol Treat 2003;14: N=204 pts MAL Cryotherapy Placebo % complete response Overall Thin lesions Moderate lesions Lesions on face Lesions on scalp
24 AK: Clinical result Actinic keratosis before treatment* Actinic keratosis after Metvix- (two treatment cycles) treatment*, after 3 months * Pariser DM et al; J Am Acad Dermatol 2003; 48(2):
25 25
26 MAL- in Actinic Keratosis 26
27 Cosmetic Outcome (Investigator) in AK Percent Australia: Fractionated and single freeze-thaw cryotherapy Metvix Cryotherapy Fair Good Excellent * Pariser DM et al; J Am Acad Dermatol 2003; 48(2):
28 Patient preference: actinic keratosis Pooled data, Phase III studies: Patients prefer MAL to previously received treatments vs cryotherapy N=102 0 vs 5-FU N=21 0 vs surgery N=37 best Cryotherapy best 5-FU best Surgery best * Pariser DM et al; J Am Acad Dermatol 2003; 48(2):
29 Indications Indications Thin/non-hyperkeratotic and non-pigmented AKs on face and scalp + contraindications Hypersensitivity to MAL or any of the excipients sbcc and/or nbcc unsuitable for other therapies Morpheaform BCC Porphyria 29
30 Other indications Diagnostic tool Rejuvenation Acne Rosacea Infections: - mycoses - MRSA 30
31 Photodynamic diagnosis: PDD Fluorescence guided biopsy Detection clinical invasion Tumor margin Control of efficacy of treatment Development of special devices with high selectivity for tumor tissue (NMSC) 31
32 Extramammary Paget s Disease (EMPD) Rare intraepithelial neoplasm arising in apocrine glandbearing skin In situ vs. invasive disease 2 Types Primary cutaneous Secondary: underlying neoplasm internal malignancy 32
33 Standard treatment in situ EMPD Surgery with intraoperative margin control Wide Local Excision (WLE) Mohs Micrographic Surgery (MMS) high recurrence rate (31-61 %) & significant morbidity & discomfort 33
34 Case report Woman of years old In situ peri-anal EMPD No associated malignancies History of Crohn s disease Pre-surgical clinical aspect 34
35 Case report Pre-and peri-operative margin delineation with MAL+ woodlight 99,8 % sensitivity; 98 % specificity in vulvary EMPD Obstet. Gynaecol. 1991: , Misas JE et al 35
36 Case report Post-surgical MAL Fluorescence Imaging Surgical WLE with VY-plasty : no complete removal! Treatment with : Topical MAL under occlusion 4 hrs and visible red light (200 J/cm²) at 2 week interval sessions 36
37 Case report: results Clinical Aspect after 3 MAL sessions 37
38 Case report: results Complete clinical & histological response rate after 4 sessions Adverse events: pain VAS 4 Cosmetic outcome: no scarring 38
39 Conclusions: role of PDD and for in situ EMPD PDD or FD is effective in detecting in situ neoplastic skin. Tumor fluorescence mapping is a useful method for border delineation and can be used to control disease clearance in the upperlayers of the skin. Multimodal approach with MMS & adjuvant treatment to improve the cure rate with minimal tissue destruction More research has to be done to optimize treatment variability's and to evaluate the long term follow-up 39
40 and Infection Mycoses: Porphyrins metabolized by dermatophytes to protoporphyrin IX fungicide effect at lower dosis than needed on keratinocytes no genotoxic or mutagenic activity no resistance till now Tested on CA and T. Rubrum 40 Conclusion : effective not first line treatment
41 and Side- effects (N = 3000) erythema 90% (1-2 weeks) + burning or itching + swelling Scaling 80% treatment: emollients crusting 26% pustulation 2% sterile damage to follicular wall treatment: - 2 weeks humid dressing - benzoyl peroxide - anxiety erosions 0,5% - healing time 6 weeks with wound dressings - irritation and anger hyper/hypopigmentation: 2% infection bacterial or viral (herpes) < 0,5% 41
42 Summary Effective in both sbcc and AK Selective accumulation in lesions : can be used for delineation of lesions and other epidermal diseases (infections) Non-invasive Minimal scarring Fast healing Excellent cosmetic outcome High patient satisfaction Minimal side effects, except pain! 42
43 THANK YOU 43
PRODUCT INFORMATION METVIX
PRODUCT INFORMATION METVIX NAME OF THE MEDICINE Methyl aminolevulinate (as hydrochloride). Structural formula: O OCH 3 NH 3 + Cl - O CAS number: 79416-27-6 DESCRIPTION Metvix cream contains 160 mg/g of
More informationA Comparison of the Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy according to the Density of Ablative Laser Channel
A Comparison of the Efficacy of Ablative Fractional Laser-assisted Photodynamic Therapy according to the Density of Ablative Laser Channel in the Treatment of Actinic Keratosis Yeo-Rye Cho, Jeong-Hwan
More informationCorporate Medical Policy
Corporate Medical Policy Dermatologic Applications of Photodynamic Therapy File Name: Origination: Last CAP Review: Next CAP Review: Last Review: dermatologic_applications_of_photodynamic_therapy 10/2003
More informationSkin disorders. Basal cell carcinoma December 2009 Anthony Ormerod, Sanjay Rajpara, and Fiona Craig ...
December 29 Anthony Ormerod, Sanjay Rajpara, and Fiona Craig.................................................. ABSTRACT INTRODUCTION: (BCC) is the most common form of skin cancer, predominantly affecting
More informationDual Wavelength Phototherapy System
Dual Wavelength Phototherapy System The AKLARUS Blue and Red Combination System is an effective, drugfree alternative for treating acne & photodamaged skin. The non-invasive Aklarus treatment has been
More informationScottish Medicines Consortium
Scottish Medicines Consortium imiquimod 5% cream (Aldara) No. (385/07) Meda Pharmaceuticals Ltd 04 April 2008 The Scottish Medicines Consortium has completed its assessment of the above product and advises
More informationNew and Emerging Therapies: Non-Melanoma Skin Cancers. David J. Goldberg, MD, JD Skin Laser and Surgery Specialists of NY/NJ
New and Emerging Therapies: Non-Melanoma Skin Cancers David J. Goldberg, MD, JD Skin Laser and Surgery Specialists of NY/NJ Disclosure Research Grant form Sensus Superficial Radiation Therapy (SRT) Modern
More informationDual wavelength (1540nm nm) mixed technology for fractional resurfacing in skin rejuvenation Background
Dual wavelength (1540nm + 10600 nm) mixed technology for fractional resurfacing in skin rejuvenation Dr. Paolo Sbano, M.D. Specialist in Dermatology and Venereology Department of Dermatology of Belcolle
More informationPhotodynamic Photorejuvenation: An 18- month Experience on Combination of ALA-IPL and a 630nm LED Continuous Light Source
Photodynamic Photorejuvenation: An 18- month Experience on Combination of ALA-IPL and a 630nm LED Continuous Light Source by Samuel Seit MBBS Neutral Bay, Sydney, Australia ABSTRACT Photodynamic therapy
More information1) Photodynamic therapy with topical 5 aminolevulinic acid is considered medically necessary and is covered for the treatment of:
Medical Policy Title: Photodynamic Therapy ARBenefits Approval: 10/26/2011 for Dermatologic Conditions Effective Date: 01/01/2012 Document: ARB0282:02 Revision Date: 03/20/2013 Code(s): 96567 Photodynamic
More informationICD 10 Codes. L82.1 Seborrheic Keratosis L82.0 Irritated Seborrheic Keratosis
Leon H. Kircik M.D. Clinical Associate Professor of Dermatology Indiana University School of Medicine Mount Sinai Medical Center, New York, NY Physicians Skin Care, PLLC Louisville, KY 1 ICD 10 Codes L82.1
More informationField vs Lesional Therapies for AKs 3/2/2019, 9:00-12 AM
Dilemmas and Challenges in Skin Cancer Therapies and Management Field vs Lesional Therapies for AKs 3/2/2019, 9:00-12 AM Roger I. Ceilley, M.D. Clinical Professor of Dermatology The University of Iowa
More informationBL-5010P A NOVEL PRE-FILLED APPLICATOR FOR THE NON-SURGICAL REMOVAL OF SKIN LESIONS
BL-5010P A NOVEL PRE-FILLED APPLICATOR FOR THE NON-SURGICAL REMOVAL OF SKIN LESIONS 25 Skin lesions Miri Seiberg, PhD 26 Skin lesions A part of the skin that has an abnormal growth or appearance compared
More informationI have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee
I have a skin lump doc! What s next? 12 th August 2017 Dr. Sue-Ann Ho Ju Ee Some thoughts Is this skin cancer? How common is this? How likely is this in this patient? What happens next if it s something
More informationA Retrospective Study of Treatment of Squamous Cell Carcinoma In situ. Övermark, Meri.
https://helda.helsinki.fi A Retrospective Study of Treatment of Squamous Cell Carcinoma In situ Övermark, Meri 2016 Övermark, M, Koskenmies, S & Pitkanen, S 2016, ' A Retrospective Study of Treatment of
More informationFluorescence Diagnosis For Follow- Up Of Mycosis Fungoides Therapy
Fluorescence Diagnosis For Follow- Up Of Mycosis Fungoides Therapy Bosseila M*, Al-Helf F, El-Sayed A, Mahgoub D*, Metwally D*, El-Shaer M Dermatology Dept*, Cairo Univ., Dermatology Dept, National Research
More informationPhotodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions
Photodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions Policy Number: Original Effective Date: MM.02.016 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST
More informationCutaneous Malignancies: A Primer COPYRIGHT. Marissa Heller, M.D.
Cutaneous Malignancies: A Primer Marissa Heller, M.D. Associate Director of Dermatologic Surgery Department of Dermatology Beth Israel Deaconess Medical Center December 10, 2016 Skin Cancer Non-melanoma
More informationDr. Mohammed T Omar Associate professor CAMS Mobile: Office: 2074
INFRARED Therapy Dr. Mohammed T Omar Associate professor CAMS E-mail-momarar@ksu.edi.sa Dr.taher-M@yahoo.com Mobile: 0542115404 Office: 2074 Objectives Following completion of this lecture the student
More informationAllergic contact dermatitis to topical prodrugs used in photodynamic therapy Cordey, Helen; Ibbotson, Sally
University of Dundee Allergic contact dermatitis to topical prodrugs used in photodynamic therapy Cordey, Helen; Ibbotson, Sally Published in: Photodermatology, Photoimmunology & Photomedicine DOI: 10.1111/phpp.12252
More informationANNEX I SUMMARY OF PRODUCT CHARACTERISTICS
ANNEX I SUMMARY OF PRODUCT CHARACTERISTICS 1 1. NAME OF THE MEDICINAL PRODUCT Picato 150 micrograms/gram gel 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each gram of gel contains 150 mcg of ingenol mebutate.
More informationDERMATOLOGIC APPLICATIONS OF PHOTODYNAMIC THERAPY
DERMATOLOGIC APPLICATIONS OF PHOTODYNAMIC THERAPY Non-Discrimination Statement and Multi-Language Interpreter Services information are located at the end of this document. Coverage for services, procedures,
More informationMust be dispensed to and applied by a physician.
TRADENAME (methyl aminolevulinate) Cream, 16.8% For Topical Use Only. Not for Ophthalmic, Oral, or Intravaginal Use Must be dispensed to and applied by a physician. DESCRIPTION TRADENAME Cream is an oil
More informationMedical Policy. MP Dermatologic Applications of Photodynamic Therapy
Medical Policy MP 2.01.44 BCBSA Ref. Policy: 2.01.44 Last Review: 12/27/2017 Effective Date: 12/27/2017 Section: Medicine Related Policies 2.01.47 Light Therapy for Psoriasis 8.01.06 Oncologic Applications
More informationLearning Objectives. Tanning. The Skin. Classic Features. Sun Reactive Skin Type Classification. Skin Cancers: Preventing, Screening and Treating
Learning Objectives Skin Cancers: Preventing, Screening and Treating Robert A. Baldor, MD, FAAFP Professor, Family Medicine & Community Health University of Massachusetts Medical School Distinguish the
More informationInformation and Consent For Intracel
Information and Consent For Intracel What is Intracel? Intracel is a state of the art treatment for stimulating skin without the down time of total resurfacing using traditional invasive treatments. The
More informationOpinion 6 March 2013
The legally binding text is the original French version TRANSPARENCY COMMITTEE Opinion 6 March 2013 EFFALA 8 mg, medicated plaster B/4 sachets (CIP code: 34009 397 996 4 3) B/8 sachets (CIP code: 34009
More informationKnow who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated
Lindy P. Fox, MD Assistant Professor Director, Hospital Consultation Service Department of Dermatology University of California, San Francisco Applies to adults without history of malignancy or premalignant
More informationSUN, SAVVY AND SKIN : A REVIEW OF SKIN CANCER IN SOUTH AFRICA AND BEYOND
SUN, SAVVY AND SKIN : A REVIEW OF SKIN CANCER IN SOUTH AFRICA AND BEYOND Dr Lester M. Davids Redox Laboratory, Dept of Human Biology University of Cape Town Crafting a Road Map for Research on Sun Exposure
More informationfluorouracil 0.5% / salicylic acid 10% cutaneous solution (Actikerall ) SMC No. (728/11) Almirall S.A.
fluorouracil 0.5% / salicylic acid 10% cutaneous solution (Actikerall ) SMC No. (728/11) Almirall S.A. 09 September 2011 The Scottish Medicines Consortium (SMC) has completed its assessment of the above
More informationTOPICAL TREATMENT OF ACTINIC KERATOSIS
TOPICAL TREATMENT OF ACTINIC KERATOSIS Gary Goldenberg, MD Goldenberg Dermatology, PC Assistant Clinical Professor of Dermatology The Icahn School of Medicine at Mount Sinai Hospital Conflicts of Interest
More informationBackground 1/29/2018. Lasers and Lights for Onychomycosis KEYVAN NOURI, MD. Keyvan Nouri, M.D. White superficial. onychomycosis
Lasers and Lights for Onychomycosis KEYVAN NOURI, MD Keyvan Nouri, M.D. Professor of Dermatology, Ophthalmology, Otolaryngology & Surgery Louis C. Skinner, Jr., M.D. Endowed Chair in Dermatology Richard
More informationThe legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION. 26 November 2008
The legally binding text is the original French version TRANSPARENCY COMMITTEE OPINION 26 November 2008 ALDARA 5%, cream Box of 12 sachets of 250 mg (CIP: 349 204-4) Applicant: MEDA PHARMA imiquimod ATC
More informationMULTIDIODE PDT 630 TM
MULTIDIODE PDT 630 TM DERMA Photodynamic therapy with 630nm laser Intralesional and percutaneous photodynamic therapy with PDT 630nm laser for benign and precancerous skin lesions MULTIDIODE PDT 630 TM
More informationDeveloping the next generation of dermatology products to treat serious skin diseases
Developing the next generation of dermatology products to treat serious skin diseases Tom Wiggans Chairman and Chief Executive Officer www.peplin.com Forward Looking Statements This presentation contains
More informationRhenium-SCT Questions and answers for physicians and medical personnel
Questions and answers for physicians and medical personnel Frequently asked questions Bringing back Quality of Life. single-session painless aesthetic FAQs Doctors and Specialist Staff 1. What is Rhenium
More informationExtreme dermatoheliosis: How to approach the severely sun damaged patient
Extreme dermatoheliosis: How to approach the severely sun damaged patient Anokhi Jambusaria MD, MSCE Staff Dermatologist Baylor Scott and White Health Round Rock, TX I have no relevant conflicts of interest
More informationF066: Photodynamic Therapy in Medical and Aesthetic Dermatology
F066: Photodynamic Therapy in Medical and Aesthetic Dermatology Improving Efficacy and Maintaining Safety of ALA-PDT American Academy of Dermatology 77 th Annual Meeting Washington, DC Maria M. Tsoukas,
More informationAESTHETIC DERMATOLOGY AND LASER Dra. Soledad Sáenz
AESTHETIC DERMATOLOGY AND LASER Dra. Soledad Sáenz European society for cosmetic and aesthetic dermatology European society laser dermatology An approach to fillers complications Early-onset complications
More informationDiagnosis and Management of Actinic Keratosis (AKs)
Diagnosis and Management of Actinic Keratosis (AKs) Andrei Metelitsa, MD, FRCPC, FAAD Co-Director, Institute for Skin Advancement Clinical Associate Professor, Dermatology University of Calgary, Canada
More informationKnow who is at risk: LOOK! for ABCDs, rapidly changing lesions, do a biopsy when indicated
Lindy P. Fox, MD Associate Professor Director, Hospital Consultation Service Department of Dermatology University of California, San Francisco Applies to adults without history of malignancy or premalignant
More informationDermatopathology: The tumor is composed of keratinocytes which show atypia, increase mitoses and abnormal mitoses.
Squamous cell carcinoma (SCC): A common malignant tumor of keratinocytes arising in the epidermis, usually from a precancerous condition: 1- UV induced actinic keratosis, usually of low grade malignancy.
More informationClinical characteristics
Skin Cancer Fernando Vega, MD Seattle Healing Arts Clinical characteristics Precancerous lesions Common skin cancers ACTINIC KERATOSIS Precancerous skin lesions Actinic keratoses Dysplastic melanocytic
More informationPhotodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions
Photodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions Policy Number: Original Effective Date: MM.02.016 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST
More informationA Novel Approach for Acne Treatment
A Novel Approach for Acne Treatment E.V. Ross, M.D.; M.A. Blair, M.D.; B.S. Graham, M.D.; Naval Medical Center, San Diego, CA D.Y. Paithankar, Ph.D.; B.A. Saleh, M.Eng.; Candela Corporation, Wayland, MA
More informationNO MORE NEWS AN EVIDENCE BASED APPROACH ON LASERS IN SKIN OF COLOR PATIENTS DR. EDUARDO WEISS, M.D., FAAD
NO MORE NEWS AN EVIDENCE BASED APPROACH ON LASERS IN SKIN OF COLOR PATIENTS DR. EDUARDO WEISS, M.D., FAAD KEY POINTS Hispanics/Latinos are the fastest growing segment of the skin of color population Use
More informationPHYSICIANS GUIDE. Understanding Fraxel TM Laser Treatment
PHYSICIANS GUIDE Understanding Fraxel TM Laser Treatment For more information visit our web site www.reliantlaser.com Reliant Technologies Inc. 5375 Mira Sorrento Pl, Suite 100 San Diego, CA 92121 Phone:
More informationSkin lesions The Good and the Bad. Dr Virginia Hubbard Ipswich Hospital NHS Trust Barts and the London School of Medicine and Dentistry
Skin lesions The Good and the Bad Dr Virginia Hubbard Ipswich Hospital NHS Trust Barts and the London School of Medicine and Dentistry Case 1 32 year old woman Australian Lesion on back New hair growing
More informationIndex. derm.theclinics.com. Note: Page numbers of article titles are in boldface type.
Note: Page numbers of article titles are in boldface type. A Abnormal wound healing Acne and cybereducation, 131 and Google, 129 131 and online dangers, 131, 132 reliable online resources on, 130 self-proclaimed
More informationSTUDY. Laser-Mediated Photodynamic Therapy of Actinic Keratoses
STUDY Laser-Mediated Photodynamic Therapy of Actinic Keratoses Macrene R. Alexiades-Armenakas, MD, PhD; Roy G. Geronemus, MD Objective: To assess the safety and efficacy of the longpulsed pulsed dye laser
More informationArisa Ortiz, MD Director, Laser and Cosmetic Dermatology Assistant Clinical Professor Department of Dermatology UC San Diego
1 What s New in Skin Tightening? Arisa Ortiz, MD Director, Laser and Cosmetic Dermatology Assistant Clinical Professor Department of Dermatology UC San Diego 2 Disclosures BTL, InMode, Sciton Equipment
More informationNon-Ablative Rejuvenation
Non-Ablative Rejuvenation Denise Baker, MD Non-Ablative Skin Rejuvenation Denise Baker, MD The following potential conflict of interest relationships are germane to my presentation. Intrinsic Aging Inevitably
More informationINTENSE PULSED LIGHT VERSUS ADVANCED FLUORESCENT TECHNOLOGY PULSED LIGHT FOR PHOTODAMAGED SKIN: A SPLIT-FACE PILOT COMPARISON
22 COPYRIGHT 2007 INTENSE PULSED LIGHT VERSUS ADVANCED FLUORESCENT TECHNOLOGY PULSED LIGHT FOR PHOTODAMAGED SKIN: A SPLIT-FACE PILOT COMPARISON Martin Braun MD Vancouver Laser & Skin Care Centre Inc, Vancouver,
More informationMOHS MICROGRAPHIC SURGERY: AN OVERVIEW
MOHS MICROGRAPHIC SURGERY: AN OVERVIEW SKIN CANCER: Skin cancer is far and away the most common malignant tumor found in humans. The most frequent types of skin cancer are basal cell carcinoma, squamous
More informationPhotodynamic Therapy with Ablative Carbon Dioxide Fractional Laser in Treatment of Actinic Keratosis
PDT with Ablative CO 2 Fractional Laser for AK Ann Dermatol Vol. 25, No. 4, 2013 http://dx.doi.org/10.5021/ad.2013.25.4.417 ORIGINAL ARTICLE Photodynamic Therapy with Ablative Carbon Dioxide Fractional
More informationLiving Beyond Cancer Skin Cancer Detection and Prevention
Living Beyond Cancer Skin Cancer Detection and Prevention Cutaneous Skin Cancers Identification Diagnosis Treatment options Prevention What is the most common cancer in people? What is the most common
More informationDERMATOLOGY ROTATION: COMPETENCY-BASED GOALS AND OBJECTIVES
UNC DIVISION OF PLASTIC AND RECONSTRUCTIVE SURGERY DERMATOLOGY ROTATION: COMPETENCY-BASED GOALS AND OBJECTIVES MEDICAL KNOWLEDGE A. Anatomy/Physiology/Embryology Goal: The resident will have knowledge
More informationDevelopment of Low-Cost Photodynamic Therapy Device
Vol. 112 (2007) ACTA PHYSICA POLONICA A No. 5 Proceedings of the International School and Conference on Optics and Optical Materials, ISCOM07, Belgrade, Serbia, September 3 7, 2007 Development of Low-Cost
More informationJust the Facts Ma am
Aesthetic Lasers, IPL, and LED Just the Facts Ma am Patrick Clark, PhD, CMLSO Founder Medical Laser Dynamics, Inc. Director of Clinical Education Program Founder University of Texas Southwestern Medical
More informationPDT in Medical and Aesthetic Dermatology: An European Perspective. Rolf-Markus Szeimies Recklinghausen, Germany
PDT in Medical and Aesthetic Dermatology: An European Perspective Rolf-Markus Szeimies Recklinghausen, Germany DISCLOSURE OF RELATIONSHIPS WITH INDUSTRY Rolf-Markus Szeimies, MD PhD F066 Photodynamic Therapy
More informationPeriocular skin cancer
Periocular skin cancer Information for patients Skin cancer involving the skin of the eyelid or around the eye is called a periocular skin cancer. Eyelid skin cancers occur most often on the lower eyelid,
More informationPhotodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions
Photodynamic Therapy for the Treatment of Actinic Keratoses and Other Skin Lesions Policy Number: Original Effective Date: MM.02.016 04/01/2008 Line(s) of Business: Current Effective Date: HMO; PPO; QUEST
More informationTopical Photodynamic Therapy Using Intense Pulsed Light for Treatment of Actinic Keratosis: Clinical and Histopathologic Evaluation
Topical Photodynamic Therapy Using Intense Pulsed Light for Treatment of Actinic Keratosis: Clinical and Histopathologic Evaluation HYUNG SU KIM, MD,JONG YEOP YOO, MD,KWANG HYUN CHO, MD,OH SANG KWON, MD,
More informationBenign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc
1 Benign versus Cancerous Lesions How to tell the difference FMF 2014 Christie Freeman MD, CCFP, DipPDerm, MSc Benign lesions Seborrheic Keratoses: Warty, stuck-on Genetics and birthdays Can start in late
More informationRightLight TM Technology Enhanced Dye Wavelengths. WHITE PAPER Synchro VasQ
RightLight TM Technology Enhanced Dye Wavelengths WHITE PAPER Synchro VasQ DEKA White Paper SYNCHRO VASQ February 2013 RightLight TM Technology Enhanced Dye Wavelengths Prof. P. Campolmi, Prof. G.Cannarozzo,
More informationLocal Coverage Determination (LCD) for Actinic Keratosis (L28232)
Page 1 of 12 Search Home Medicare Medicaid CHIP About CMS Regulations & Guidance Research, Statistics, Data & Systems Outreach & Education People with Medicare & Medicaid Questions Careers Newsroom Contact
More informationAesthetic Laser Industry Why the excitement?
Laser Tissue Interaction Technology meets medicine Aesthetic Laser Industry Why the excitement? Laser Aesthetic Market Growth Acceptance Market Affordability 71% of patients who have cosmetic surgery earn
More informationTreat Your Patients Better
Treat Your Patients Better With Fractional Innovation Introducing For Skin Rejuvenation By Small Smart Systems Glabellar Frown Lines Crow s Feet (Peri-orbital Lines) Forehead worry lines Improves: Wrinkles
More informationIntraoperative Dermoscopy for Identification of Early Basal Cell Carcinomas in Basal Cell Nevus Syndrome
Intraoperative Dermoscopy for Identification of Early Basal Cell Carcinomas in Basal Cell Nevus Syndrome Disclosures I have no industry related, financial, or other disclosures Goals Discuss the clinical
More informationPatient Guide. The precise answer for tackling skin cancer. Brachytherapy: Because life is for living
Patient Guide Brachytherapy: The precise answer for tackling skin cancer Because life is for living Overview of skin cancer Skin cancer is the most common cancer worldwide. In fact more people are diagnosed
More informationProposal for a 2-stage RCT in high risk primary SCC: COMMISSAR Catherine Harwood Barts Health NHS Trust / QMUL
Proposal for a 2-stage RCT in high risk primary SCC: COMMISSAR Catherine Harwood Barts Health NHS Trust / QMUL on behalf of Dr Louise Lansbury, Prof Fiona Bath-Hextall Nottingham Centre for Evidence Based
More informationIn-vivo histopathological study of YouLaser MT interaction with the skin. A laser device emitting combined 1540 and nm wavelengths.
Histology report No. 02/04-12, date April 2nd, 2012 Page 1 In-vivo histopathological study of YouLaser MT interaction with the skin. A laser device emitting combined 1540 and 10600 nm wavelengths. Paolo
More informationIntroduction to Physical Agents Part II: Principles of Heat for Thermotherapy
Introduction to Physical Agents Part II: Principles of Heat for Thermotherapy Mohammed TA, Omar momarar@ksu.edu.sa Dr.taher_m@yahoo.com Mobile : 542115404 Office number: 2074 Objectives After studying
More informationCLINICAL EVALUATION REPORT ON THE EFFICACY AND SAFETY OF THE CORE SYSTEM FOR FACIAL ENHANCEMENT TREATMENTS
CLINICAL EVALUATION REPORT ON THE EFFICACY AND SAFETY OF THE CORE SYSTEM FOR FACIAL ENHANCEMENT TREATMENTS BACKGROUND Efforts to improve fractional ablative laser systems have led to the development of
More informationComparison of PpIX accumulation and destruction during. methyl-aminolevulinate photodynamic therapy (MAL-PDT) of
Comparison of PpIX accumulation and destruction during methyl-aminolevulinate photodynamic therapy (MAL-PDT) of skin tumours located at acral and non-acral sites J. S. Tyrrell 1, C Morton 2, S. M. Campbell
More informationStudy of the Effect of PDL Treatment of Recalcitrant Plantar Warts
ORIGINAL ARTICLE Study of the Effect of PDL Treatment of Recalcitrant Plantar Warts Ahmed Al-Mutairi, MD, Muhammad Elkashlan, MD Department of Dermatology, Ahmadi Hospital, Kuwait ABSTRACT Forty patients
More informationMulti-Application Platform. Summary of Peer-reviewed Articles for Various Clinical Indications April 2016
Multi-Application Platform Summary of Peer-reviewed Articles for Various Clinical Indications April 2016 Various Clinical Indications Atrophic acne scars and acne Photo-aged skin, pigmentation & hyperpigmentation
More informationGlenn D. Goldman, MD. University of Vermont Medical Center. University of Vermont College of Medicine
Glenn D. Goldman, MD University of Vermont Medical Center University of Vermont College of Medicine Recognize and identify the main types of skin cancer and their precursors Identify and understand new
More informationGeneral information about skin cancer
Skin Cancer General information about skin cancer Key points Skin cancer is a disease in which malignant (cancer) cells form in the tissues of the skin. There are different types of cancer that start in
More informationBBLs BroadBand Light. Daryl Mossburg, RN BSN Clinical Specialist Sciton, Inc. All rights reserved.
BBLs BroadBand Light Daryl Mossburg, RN BSN Clinical Specialist 1 2009 Sciton, Inc. All rights reserved. BBL - BroadBand Light BBL module incorporated into JOULE BBLs Standalone System 2 2009 Sciton, Inc.
More informationMohs surgery for the nail unit
Mohs surgery for the nail unit olivier.cogrel@chu-bordeaux.fr Dermatologic surgery, Mohs surgery and lasers unit CHU Bordeaux, France Squamous cell carcinoma +++ Acral lentiginous melanoma Lichte et al.
More informationCurrent Treatment of Verruca. Mickey D. Stapp, DPM Evans, GA
Current Treatment of Verruca Mickey D. Stapp, DPM Evans, GA Etiology Infection of the epithelium with HPV Affects 7-10 percent of population Plantar verruca caused by HPV 1,2,4,60 or 63 Andrews Diseases
More informationDermatologic Applications of Photodynamic Therapy
Dermatologic Applications of Photodynamic Therapy Policy Number: 2.01.44 Last Review: 3/2014 Origination: 8/2007 Next Review: 3/2015 Policy Blue Cross and Blue Shield of Kansas City (Blue KC) will provide
More informationSkin Cancer. 5 Warning Signs. American Osteopathic College of Occupational and Preventive Medicine OMED 2012, San Diego, Monday, October 8, 2012 C-1
Skin Cancer AMERICAN OSTEOPATHIC COLLEGE OF OCCUPATIONAL & PREVENTIVE MEDICINE OMED 2012 October 8, 2012 E. Robert Wanat II, D.O., M.P.H. Learning Objectives: Identify the 3 Basic Types of Skin Cancer
More informationIncontinence Associated Dermatitis. Moisture Associated Dermatitis 8/31/2017. Goals of Presentation. Differentiating and Controlling
Incontinence Associated Dermatitis Moisture Associated Dermatitis Differentiating and Controlling Goals of Presentation This presentation will attempt to: Identify causes and risk factors for IAD and MASD
More informationBISON. Accento. 755nm Long Pulsed Alexandrite Laser 1064nm Long Pulsed Nd:YAG Laser FOR EXPORT ONLY
BISON D www.bisonmedical.com U A ong Pulsed Alexandrite aser 1064nm ong Pulsed Nd:YAG aser S I N G E ong Pulsed Alexandrite aser FOR EXPORT ONY Dual & Single D U A & 1064nm Dual Wavelength aser ong Pulsed
More informationPresentation Product & clinics
Presentation Product & clinics Design What s Long Pulse Nd:YAG? medium YAG (Yuttrium Aluminum Garnet : Y 3 Al 5 O 12 ) + Nd 3+ The Wavelength Penetrates All kind of Hair removal Each laser possesses specific
More informationNonmelanoma skin cancers
Skin cancer Philip Clarke Nonmelanoma skin cancers Treatment options Background Australia has one of the highest skin cancer rates in the world. Early detection and treatment of skin cancer is vital to
More informationSkin NCG (Anglia East & Anglia West)
Guidelines for the Management of Basal Cell Carcinoma Skin NCG (Anglia East & Anglia West) Author: N R Telfer, G B Colver and C A Morton Approved by: Anglia Cancer Network Skin NCG Approved on: Reviewed
More informationDermoscopy: Recognizing Top Five Common In- Office Diagnoses
Dermoscopy: Recognizing Top Five Common In- Office Diagnoses Vu A. Ngo, DO Department of Family Medicine and Dermatology Choctaw Nation Health Services Authority Learning Objectives Introduction to dermoscopy
More informationActinic keratosis (AK): Dr Sarma s simple guide
Actinic keratosis (AK): Dr Sarma s simple guide Actinic keratosis is a very common lesion that you will see in your day-to-day practice. First, let me explain the name Actinic keratosis. It means keratosis
More informationIdentifying Skin Cancer. Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018
Identifying Skin Cancer Mary S. Stone MD Professor of Dermatology and Pathology University of Iowa Carver College of Medicine March, 2018 American Cancer Society web site Skin Cancer Melanoma Non-Melanoma
More informationPhotodynamic Therapy with Ablative Carbon Dioxide Fractional Laser for Treating Bowen Disease
Ann Dermatol Vol. 25, No. 3, 2013 http://dx.doi.org/10.5021/ad.2013.25.3.335 ORIGINAL ARTICLE Photodynamic Therapy with Ablative Carbon Dioxide Fractional Laser for Treating Bowen Disease Sue Kyung Kim,
More informationPRODUCT MONOGRAPH METVIX. methyl aminolevulinate topical cream 168 mg/g (as methyl aminolevulinate hydrochloride) Anti-neoplastic Agent
PRODUCT MONOGRAPH Pr METVIX methyl aminolevulinate topical cream 168 mg/g (as methyl aminolevulinate hydrochloride) Antineoplastic Agent Galderma Canada Inc. 55 Commerce Valley Drive West 4 th Floor Thornhill,
More informationIntegumentary System
Integumentary System Integumentary System Skin, hair, and nails. Skin: Epidermis: outer layer. Dermis: also called corium, or true skin. Subcutaneous fascia: innermost layer. Integumentary Glands Sudoriferous:
More informationStudy the Effect of Illumination Time Parameter of Diode Laser on Wound Healing Process
The 1 st Regional Conference of Eng. Sci. NUCEJ Spatial ISSUE vol.11, No.2, 2008 pp 536-543 Study the Effect of Illumination Time Parameter of Diode Laser on Wound Healing Process Assist. Prof. Dr. Munqith
More informationClearSkin. Er:Glass 1540nm Laser Module. Orly Baror Gal, Eng.BioMedical. Clinical Applications Specialist
ClearSkin Er:Glass 1540nm Laser Module Orly Baror Gal, Eng.BioMedical Clinical Applications Specialist Acne - Introduction 2 Acne Vulgaris Very common Affects 80% of the population Almost every person
More informationPHOTOTHERAPY: WHAT DO WE KNOW AND HOW DOES IT WORK? Suite 3/36 O'Riordan Street Alexandria, Sydney NSW Australia
PHOTOTHERAPY: WHAT DO WE KNOW AND HOW DOES IT WORK? Suite 3/36 O'Riordan Street Alexandria, Sydney NSW Australia 2015 02 8331 8933 info@infinity-led.com.au DOCTORATE IN HEALTH SCIENCE DEAKIN UNIVERSITY
More informationMING H. JIH, MD,PHD, PAUL M. FRIEDMAN, MD,LEONARD H. GOLDBERG, MD,AND ARASH KIMYAI-ASADI, MD. Methods Phase I: Retrospective (Group 1)
Curettage prior to Mohs Micrographic Surgery for Previously Biopsied Nonmelanoma Skin Cancers: What Are We Curetting? Retrospective, Prospective, and Comparative Study MING H. JIH, MD,PHD, PAUL M. FRIEDMAN,
More information